home / stock / lyel / lyel articles
Lyell Immunopharma, Inc. (NASDAQ: LYEL) shares are trading higher after the company announced that the U.S. Food and Drug Administration (FDA)...
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (NASDAQ:LYEL), a clinical?stage T-cell reprogramming c...
News, Short Squeeze, Breakout and More Instantly...
Lyell Immunopharma Inc. Company Name:
LYEL Stock Symbol:
NASDAQ Market:
Lyell Immunopharma Inc. Website:
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 73.0% to $0.4585 on volume of 640,087,036 shares Ocean Power Technologies Inc. (OPTT) rose 34.9% to $0.1812 on volume of 396,326,565 shares NVIDIA Corporation (NVDA) rose 0.2% to $1...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 56.4% to $0.21 on volume of 112,154,340 shares Rivian Automotive Inc. (RIVN) rose 31.8% to $15.76 on volume of 70,797,368 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 48.3% to $...
Dose-dependent antitumor clinical activity in ROR1+ relapsed/refractory triple-negative breast cancer; 40% objective response rate and 60% clinical benefit rate at the highest dose cleared to date (150 x 10 6 CAR T cells) First demonstration that CAR T cells enhanced with anti-exhaus...